Dipan Mehta positive on pharma sector

Dipan Mehta, member at BSE & NSE is positive on pharma sector.

Dipan Mehta, Member at BSE & NSE told CNBC-TV18, "We bear very positive on the pharma sector as a whole and considering the complexities and the risk factors with regards to new product registration, with regards to regulatory Food and Drug Administration (FDA) action and if you not a total hands on experts in the Pharma industry, its better to buy the pharma stocks as a basket and go for a mutual fund which is focused on health care and pharma, that itself should deliver a good safe returns."

"The reason why the other midcap pharma shares are doing well of course one is that there are specific issues relating to each of these stocks. But on the whole if you see the December quarter, the numbers were exceptionally good across the board for most pharma companies and I would read them as a best performer for December quarter and typically when you have a good quarter, you tend to follow it up with another good quarter. So, my sense is that March will also turnout to be a very good quarter for the pharma companies and some kind of pre-result buying seems to be creeping in and valuation wise also these companies are pretty decent," he added.

"We have seen that the India business – the domestic market, the volumes over there have certainly picked up from whatever the market research surveys which have been done and which get released from time to time. So, the sector may surprise investors on the positive side when it comes out with numbers."

Anda sedang membaca artikel tentang

Dipan Mehta positive on pharma sector

Dengan url

http://sehatgayahidup.blogspot.com/2014/04/dipan-mehta-positive-on-pharma-sector.html?m=0

Anda boleh menyebar luaskannya atau mengcopy paste-nya

Dipan Mehta positive on pharma sector

namun jangan lupa untuk meletakkan link

Dipan Mehta positive on pharma sector

sebagai sumbernya